Gene: TGM2
Official Full Name: transglutaminase 2provided by VGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01307 | TGM2 Knockout cell line(MDCK) | Dog | TGM2 | 1:3~1:4 | Negative | Online Inquiry |
KO05459 | TGM2 Knockout cell line (HeLa) | Human | TGM2 | 1:3~1:6 | Negative | Online Inquiry |
KO05460 | TGM2 Knockout cell line (HCT 116) | Human | TGM2 | 1:2~1:4 | Negative | Online Inquiry |
KO05461 | TGM2 Knockout cell line (A549) | Human | TGM2 | 1:3~1:4 | Negative | Online Inquiry |
TGM2 Gene Knockout Cell Lines are specialized biological models generated through advanced genetic engineering techniques that facilitate the targeted disruption of the transglutaminase 2 (TGM2) gene. TGM2 plays a crucial role in various physiological processes, including cell adhesion, apoptosis, and extracellular matrix remodeling. By creating knockout cell lines, researchers can study the specific functions and pathways impacted by the absence of TGM2, enhancing our understanding of its involvement in diseases such as cancer, fibrosis, and neurodegenerative disorders.
The primary mechanism by which TGM2 functions involves its activity as an enzyme that catalyzes the cross-linking of proteins, which is critical in cellular signaling and structural integrity. By utilizing these gene knockout cell lines, scientists can experimentally dissect the downstream effects of TGM2's deficiency or aberrant function, thereby unlocking valuable insights into disease mechanisms and potential therapeutic targets.
The scientific importance of TGM2 Gene Knockout Cell Lines is multifaceted. In research settings, they serve as invaluable tools for drug discovery, allowing for high-throughput screening of compounds that may modulate TGM2 activity. In clinical settings, understanding TGM2's role could lead to novel biomarkers for disease prognostics or therapeutic interventions, ultimately improving patient outcomes.
Compared to alternative models, such as wild-type cell lines or TGM2 overexpressing variants, the knockout lines provide a clearer and more relevant biological context for studying the gene's loss-of-function scenarios. This specificity enhances experimental precision, paving the way for more reliable and reproducible results.
For researchers and clinicians, the value of TGM2 Gene Knockout Cell Lines extends beyond just an experimental tool; they represent a gateway to uncovering revolutionary data that could inform future therapies and protocols. Our commitment to providing high-quality biological products is underscored by our extensive experience in genetic engineering and regenerative medicine, ensuring that our offerings meet the highest standards of scientific rigor and relevance.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.